Filing Details
- Accession Number:
- 0001415889-25-001930
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-23 16:17:32
- Reporting Period:
- 2025-01-21
- Accepted Time:
- 2025-01-23 16:17:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1267813 | Marinus Pharmaceuticals Inc. | MRNS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1486429 | Elan Ezickson | 5 Radnor Corporate Center, Suite 500 100 Matsonford Rd Radnor PA 19087 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-01-21 | 1,600 | $0.54 | 10,900 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 represent shares of common stock of Marinus Pharmaceuticals, Inc. (the "Company") sold by the reporting person pursuant to a Rule 10b5-1 Plan adopted on March 10, 2024 to cover tax obligations in connection with the vesting of restricted stock units.